Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy

被引：47

作者：

Durrant, L. G. ^{[1
]}

Noble, P. ^{[1
]}

Spendlove, I. ^{[1
]}

机构：

[1] Univ Nottingham, City Hosp, Acad Dept Clin Oncol, Nottingham NG5 1PB, England

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2012年 / 167卷 / 02期

关键词：

cancer vaccine; glycolipid; glycosylation; immunotherapy; monoclonal antibody; CELL-LUNG-CANCER; ALPHA-5-BETA-1 INTEGRIN RECEPTOR; MOUSE MONOCLONAL-ANTIBODIES; N-GLYCOLYLNEURAMINIC ACID; HUMAN BREAST-CANCER; SIALYL-LEWIS-X; GM3; GANGLIOSIDE; MELANOMA PATIENTS; CONJUGATE VACCINE; ADJUVANT VACCINATION;

D O I：

10.1111/j.1365-2249.2011.04516.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Research into aberrant glycosylation and over-expression of glycolipids on the surface of the majority of cancers, coupled with a knowledge of glycolipids as functional molecules involved in a number of cellular physiological pathways, has provided a novel area of targets for cancer immunotherapy. This has resulted in the development of a number of vaccines and monoclonal antibodies that are showing promising results in recent clinical trials.

引用

页码：206 / 215

页数：10

共 50 条

[21] ESMO Openspecial series on new emerging targets in cancer immunotherapy
Lambertini, Matteo
ESMO OPEN, 2019, 4
[22] The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
Shanshan Yan
Yaguang Zhang
Bing Sun
Science China(Life Sciences), 2019, (02) : 179 - 186
[23] The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
Shanshan Yan
Yaguang Zhang
Bing Sun
Science China(Life Sciences), 2019, 62 (02) : 179 - 186
[24] The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
Shanshan Yan
Yaguang Zhang
Bing Sun
Science China Life Sciences, 2019, 62 : 179 - 186
[25] Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy
Wu, Qihang
Mao, Han
Jiang, Zhengting
Tang, Dong
IMMUNOLOGY, 2024, 172 (03) : 343 - 361
[26] Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin
Xiuli Zhang
Heiko Schuster
Etienne Caron
Jeffrey P. Ward
Takuro Noguchi
Yulia Ivanova
Jasreet Hundal
Cora D. Arthur
Willem-Jan Krebber
Gwenn E. Mulder
Mireille Toebes
Matthew D. Vesely
Samuel S. K. Lam
Alan J. Korman
James P. Allison
Gordon J. Freeman
Arlene H. Sharpe
Erika L. Pearce
Ton N. Schumacher
Ruedi Aebersold
Hans-Georg Rammensee
Cornelis J. M. Melief
Elaine R. Mardis
William E. Gillanders
Maxim N. Artyomov
Robert D. Schreiber
Nature, 2014, 515 : 577 - 581
[27] Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, Matthew M.
Zhang, Xiuli
Schuster, Heiko
Caron, Etienne
Ward, Jeffrey P.
Noguchi, Takuro
Ivanova, Yulia
Hundal, Jasreet
Arthur, Cora D.
Krebber, Willem-Jan
Mulder, Gwenn E.
Toebes, Mireille
Vesely, Matthew D.
Lam, Samuel S. K.
Korman, Alan J.
Allison, James P.
Freeman, Gordon J.
Sharpe, Arlene H.
Pearce, Erika L.
Schumacher, Ton N.
Aebersold, Ruedi
Rammensee, Hans-Georg
Melief, Cornelis J. M.
Mardis, Elaine R.
Gillanders, William E.
Artyomov, Maxim N.
Schreiber, Robert D.
NATURE, 2014, 515 (7528) : 577 - +
[28] The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
Yan, Shanshan
Zhang, Yaguang
Sun, Bing
SCIENCE CHINA-LIFE SCIENCES, 2019, 62 (02) : 179 - 186
[29] Editorial overview: Tumour immunology: Are we on the path to win the battle against cancer through immunotherapy?
Jewett, Anahid
CURRENT OPINION IN IMMUNOLOGY, 2018, 51 : VII - IX
[30] Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation
Brooks-Worrell, B.
Palmer, J. P.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (01): : 40 - 46

← 1 2 3 4 5 →